Yield10 Bioscience Inc is an agricultural inputs business based in the US. Yield10 Bioscience shares (YTEN) are listed on the NASDAQ and all prices are listed in US Dollars. Yield10 Bioscience employs 25 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $3.63 |
|---|---|
| 52-week range | $3.76 - $23.49 |
| 50-day moving average | $5.02 |
| 200-day moving average | $7.07 |
| Wall St. target price | $21.50 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-2.46 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.63 from 2022-01-21
| 1 week (2022-01-14) | -12.11% |
|---|---|
| 1 month (2021-12-23) | -28.96% |
| 3 months (2021-10-22) | -44.15% |
| 6 months (2021-07-23) | -54.79% |
| 1 year (2021-01-22) | -77.31% |
|---|---|
| 2 years (2020-01-22) | -47.08% |
| 3 years (2019-01-22) | 245.71% |
| 5 years (2017-01-20) | 894.52% |
| Revenue TTM | $657,000 |
|---|---|
| Gross profit TTM | $-4,421,000 |
| Return on assets TTM | -35.34% |
| Return on equity TTM | -70.44% |
| Profit margin | 0% |
| Book value | $3.79 |
| Market capitalisation | $20.2 million |
TTM: trailing 12 months
We're not expecting Yield10 Bioscience to pay a dividend over the next 12 months.
Yield10 Bioscience's shares were split on a 1:40 basis on 15 January 2020. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Yield10 Bioscience shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Yield10 Bioscience shares which in turn could have impacted Yield10 Bioscience's share price.
Over the last 12 months, Yield10 Bioscience's shares have ranged in value from as little as $3.76 up to $23.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Yield10 Bioscience's is 1.2615. This would suggest that Yield10 Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Yield10 Bioscience, Inc. , an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing oilseed Camelina to produce proprietary products; and high value seed traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.